期刊
DIABETES
卷 66, 期 9, 页码 2446-2458出版社
AMER DIABETES ASSOC
DOI: 10.2337/db16-1252
关键词
-
资金
- Sao Paulo Research Foundation [2015/01237-0]
- European Union's Horizon 2020 research and innovation programme project T2DSystems [667191]
- Innovative Medicines Initiative 2 joint undertaking (INNODIA) [115797]
- Union's Horizon 2020 research and innovation programme
- European Federation of Pharmaceutical Industries and Associations
- JDRF
- Leona M. and Harry B. Helmsley Charitable Trust
- National Health and Medical Research Council (NHMRC) [1016701]
- Leukemia & Lymphoma Society of America (Specialized Center of Research) [7001-13]
- NHMRC Senior Principal Research Fellow Fellowship [1020363]
- National Funds from Scientific Research (FNRS) [T.0036.13]
- JDRF [1-2011-589]
- Actions de Recherche Concertees de la Communaute Francaise (ARC-Belgium) [20063]
- FNRS (Belgium) [T.0107.16]
Induction of endoplasmic reticulum stress and activation of the intrinsic apoptotic pathway is widely believed to contribute to beta-cell death in type 1 diabetes (T1D). MCL-1 is an antiapoptotic member of the BCL-2 protein family, whose depletion causes apoptosis in rodent beta-cells in vitro. Importantly, decreased MCL-1 expression was observed in islets from patients with T1D. We report here that MCL-1 downregulation is associated with cytokine-mediated killing of human beta-cells, a process partially prevented by MCL-1 overexpression. By generating a beta-cell-specific Mcl-1 knockout mouse strain (beta Mcl-1KO), we observed that, surprisingly, MCL-1 ablation does not affect islet development and function. beta-Cells from beta Mcl-1KO mice were, however, more susceptible to cytokine-induced apoptosis. Moreover, beta Mcl-1KO mice displayed higher hyperglycemia and lower pancreatic insulin content after multiple low-dose streptozotocin treatment. We found that the kinase GSK3 beta, the E3 ligases MULE and bTrCP, and the deubiquitinase USP9x regulate cytokine-mediated MCL-1 protein turnover in rodent beta-cells. Our results identify MCL-1 as a critical prosurvival protein for preventing beta-cell death and clarify the mechanisms behind its downregulation by proinflammatory cytokines. Development of strategies to prevent MCL-1 loss in the early stages of T1D may enhance beta-cell survival and thereby delay or prevent disease progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据